P. Kamenickỷ

发表

[Treatment of acromegaly: a critical analysis of the last ten years].

P. Chanson, P. Kamenickỷ, 2012, Annales d'endocrinologie.

Traitement de l ’ acromégalie : qu ’ ont apporté les dix dernières années ? Une analyse critique Treatment of acromegaly : A critical analysis of the last ten years

P. Chanson, P. Kamenickỷ, 2012 .

European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)

L. Rejnmark, C. Marcocci, F. Cetani, 2021, European journal of endocrinology.

Drug-Related Hypercalcemia.

P. Kamenickỷ, A. Lecoq, M. Livrozet, 2021, Endocrinology and metabolism clinics of North America.

Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line.

M. Lombès, E. Ferrary, S. Viengchareun, 2009, Molecular endocrinology.

Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients.

P. Chanson, Jacques Young, F. Borson‐Chazot, 2015, The Journal of clinical endocrinology and metabolism.

Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients

O. Mäkitie, L. Rejnmark, M. Zillikens, 2020, Hormone Research in Paediatrics.

Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement

O. Mäkitie, L. Rejnmark, M. Zillikens, 2018, Nature Reviews Endocrinology.

Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease.

Z. Motovska, J. Pirk, Z. Straka, 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.

P. Chanson, E. Letouzé, M. Lombès, 2018, The Journal of clinical endocrinology and metabolism.

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

L. Rejnmark, P. Wicart, D. Eastwood, 2019, Nature Reviews Nephrology.

Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?

P. Chanson, J. Souberbielle, M. Lombès, 2012, The Journal of clinical endocrinology and metabolism.

OR01-3 Pathophysiology of renal calcium handling in acromegaly: What lies behind hypercalciuria?

P. Chanson, J. Souberbielle, M. Lombès, 2012 .

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement].

P. Chanson, C. Annweiler, O. Beauchet, 2014, Annales de biologie clinique.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

R. Eastell, J. S. San Martin, S. Ralston, 2019, Calcified Tissue International.

Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.

P. Chanson, E. Baudin, Jacques Young, 2011, The Journal of clinical endocrinology and metabolism.

miR-324-5p and miR-30c-2-3p Alter Renal Mineralocorticoid Receptor Signaling under Hypertonicity

Y. Marie, S. Viengchareun, L. Cheval, 2022, Cells.

Mechanism of ectopic hormone receptors in adrenal tumors and hyperplasia

A. Lacroix, P. Kamenickỷ, 2019, Current Opinion in Endocrine and Metabolic Research.

Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database

P. Chanson, A. Colao, A. Beckers, 2020, Endocrine.

[New insights in growth hormone physiology and pathophysiology].

P. Chanson, M. Lombès, P. Kamenickỷ, 2010, Annales d'endocrinologie.

An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.

G. Wuerzner, C. Llorens-Cortes, C. Gauci, 2013, The Journal of clinical endocrinology and metabolism.

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

R. Eastell, S. Ralston, M. Brandi, 2021, RMD Open.

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

G. Brabant, L. Cohen, S. Radovick, 2022, European journal of endocrinology.

Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective

L. Cohen, S. Radovick, A. Hoffman, 2019, Hormone Research in Paediatrics.

Epicardial and pericardial adiposity without myocardial steatosis in Cushing's syndrome.

P. Chanson, A. Redheuil, N. Kachenoura, 2021, The Journal of clinical endocrinology and metabolism.

Management of X-linked hypophosphatemia in adults.

M. Brandi, A. Linglart, P. Kamenickỷ, 2019, Metabolism: clinical and experimental.

Reduced Intestinal Absorption of Dipeptides via PepT1 in Mice with Diet-induced Obesity Is Associated with Leptin Receptor Down-regulation*

A. Bado, R. Farinotti, M. Buyse, 2009, Journal of Biological Chemistry.

Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships.

P. Chanson, Jacques Young, S. Brailly‐Tabard, 2010, European journal of endocrinology.

A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis

J. S. San Martin, R. Lachmann, H. Cheong, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients HORMONERESEARCH IN PÆDIATRIC S

O. Mäkitie, R. Pignolo, H. Jüppner, 2020 .

Effects of cortisol on the heart: characterization of myocardial involvement in cushing's disease by longitudinal cardiac MRI T1 mapping

P. Chanson, P. Cluzel, A. Redheuil, 2017, Journal of magnetic resonance imaging : JMRI.

Growth Hormone Response to Oral Glucose Load: From Normal to Pathological Conditions

P. Chanson, P. Kamenickỷ, M. Hage, 2019, Neuroendocrinology.

Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study

R. Eastell, S. Ralston, M. Brandi, 2022, Calcified Tissue International.

Therapeutic management of hypophosphatemic rickets from infancy to adulthood

P. Wicart, K. Briot, J. Nevoux, 2014, Endocrine connections.

Phosphate wasting disorders in adults

J. Reginster, R. Rizzoli, D. Haffner, 2018, Osteoporosis International.

Primary hyperparathyroidism in pregnancy

P. Chanson, M. Senat, A. Linglart, 2013, Endocrine.

Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT

E. Baudin, Jacques Young, M. Schlumberger, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Hyperparathyroidism in Patients With X‐Linked Hypophosphatemia

P. Chanson, E. Durand, P. Chaumet‐Riffaud, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Prevalence of enthesopathies in adults with X-linked hypophosphatemia : analysis of risk factors.

Laurence Pacot, J. Herrou, C. Roux, 2021, The Journal of clinical endocrinology and metabolism.

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X‐Linked Hypophosphatemia: A Phase 3, Single‐Arm, International Trial

J. S. San Martin, F. Rauch, T. Kubota, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans.

P. Chanson, Jacques Young, S. Brailly‐Tabard, 2010, The Journal of clinical endocrinology and metabolism.

Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.

P. Chanson, Jacques Young, A. Linglart, 2016, European journal of endocrinology.

Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma

S. Richard, P. Dahia, A. Barlier, 2020, Journal of Medical Genetics.

Prevalence of overweight and obesity in children with X-linked hypophosphatemia.

C. Audrain, A. Colao, S. Trabado, 2020, Endocrine connections.

Treating hypoparathyroidism with recombinant human parathyroid hormone (1–34): long-term safety concerns

P. Chanson, K. Briot, G. Grimon, 2020, The Lancet.

Hyperparathyroidism in patients with X-linked hypophosphatemia

P. Chanson, P. Chaumet‐Riffaud, A. Blanchard, 2019, Endocrine Abstracts.

D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly.

P. Chanson, Y. Le Bouc, P. Bougnères, 2009, European journal of endocrinology.

Management of endocrine disease: Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose.

P. Chanson, S. Salenave, P. Kamenickỷ, 2021, European journal of endocrinology.

Primary hyperparathyroidism in pregnancy.

P. Chanson, P. Kamenickỷ, A. Lecoq, 2016, Annales d'endocrinologie.

Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

P. Chanson, M. Lombès, S. Viengchareun, 2008, Endocrinology.

Benign cortisol‐secreting adrenocortical adenomas produce small amounts of androgens

P. Chanson, Jacques Young, Takashi Suzuki, 2007, Clinical endocrinology.

Cortisol and aldosterone responses to hypoglycemia and Na depletion in women with non-classic 21-hydroxylase deficiency.

P. Chanson, Jacques Young, B. Donadille, 2019, The Journal of clinical endocrinology and metabolism.

Ketoconazole in Cushing's disease: is it worth a try?

P. Chanson, A. Tabarin, Jacques Young, 2014, The Journal of clinical endocrinology and metabolism.

Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion

R. Dale, R. Mains, F. Faucz, 2023, medRxiv.

Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia

K. Briot, C. Chaussain, A. Rothenbuhler, 2017, Journal of dental research.

Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.

P. Chanson, M. Lombès, G. Mazziotti, 2014, Endocrine reviews.

Genetic mutations in sporadic pituitary adenomas—what to screen for?

P. Chanson, P. Kamenickỷ, A. Guiochon‐Mantel, 2015, Nature Reviews Endocrinology.

Acromegaly.

P. Chanson, S. Salenave, P. Kamenickỷ, 2014, Handbook of clinical neurology.

Cabergoline Tapering Is Almost Always Successful in Patients With Macroprolactinomas

P. Chanson, Jacques Young, L. Maione, 2017, Journal of the Endocrine Society.

Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early‐Onset Obesity

H. Jüppner, Ashley H. Shoemaker, A. Rothenbuhler, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Somatotroph Tumors and the Epigenetic Status of the GNAS Locus

D. Figarella-Branger, G. Assié, A. Barlier, 2021, International journal of molecular sciences.

Pituitary tumours: acromegaly.

P. Chanson, Jacques Young, S. Salenave, 2009, Best practice & research. Clinical endocrinology & metabolism.

Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.

J. Lupski, J. Wess, P. Chanson, 2014, The New England journal of medicine.

Gigantism, acromegaly, and GPR101 mutations.

P. Chanson, P. Kamenickỷ, J. Bouligand, 2015, The New England journal of medicine.

Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas

P. Chanson, M. Lombès, L. Tosca, 2018, The Journal of clinical endocrinology and metabolism.

AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells.

P. Chanson, Jacques Young, M. Lombès, 2016, Endocrine-related cancer.

Cardiac Structure and Function in Cushing's Syndrome: A Cardiac Magnetic Resonance Imaging Study

P. Chanson, A. Redheuil, É. Mousseaux, 2014, The Journal of clinical endocrinology and metabolism.

Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study.

P. Chanson, A. Tabarin, R. Scharfmann, 2021, The lancet. Diabetes & endocrinology.

Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity.

P. Chanson, M. Lombès, A. Blanchard, 2011, The Journal of clinical endocrinology and metabolism.

Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR

P. Chanson, Jacques Young, L. Maione, 2022, Endocrine connections.

Identification of predictive criteria for pathogenic variants of the Primary Bilateral Macronodular Adrenal Hyperplasia gene ARMC5 in 352 unselected patients.

A. Tabarin, J. Bertherat, G. Assié, 2022, European journal of endocrinology.

Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study

P. Chanson, Jacques Young, L. Maione, 2015, European journal of endocrinology.

Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients

P. Chanson, D. Maiter, P. Kamenickỷ, 2014, Pituitary.

McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients.

P. Chanson, Jacques Young, H. Affres, 2006, The Journal of clinical endocrinology and metabolism.

The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis

F. Rivadeneira, L. Broer, A. J. van der Lely, 2016, Neuroendocrinology.

SAT-LB60 Discordant Biological Parameters of Remission in Acromegaly Do Not Increase the Risk of Hypertension or Diabetes: A Study With the Liege Acromegaly Survey Database

P. Chanson, A. Colao, A. Beckers, 2020, Endocrine.

Hypertension in Acromegaly

P. Chanson, P. Kamenickỷ, 2020, Secondary Hypertension.

Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea.

P. Chanson, D. Chemla, S. Bobin, 2014, The Journal of clinical endocrinology and metabolism.

Mild pituitary phenotype in 3- and 12-month-old Aip-deficient male mice.

P. Chanson, V. Geoffroy, A. Guillou, 2016, The Journal of endocrinology.

Cardiovascular complications of acromegaly.

P. Chanson, L. Maione, P. Kamenickỷ, 2020, Annales d'endocrinologie.

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

S. Ralston, M. Brandi, R. Lachmann, 2023, RMD Open.

Combined anticortisolic therapy by metyrapone, ketoconazole and mitotane: an alternative to adrenalectomy in severe Cushing's syndrome

P. Chanson, E. Baudin, Jacques Young, 2010 .

Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms.

C. Roux, K. Briot, A. Rothenbuhler, 2016, European journal of endocrinology.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

R. Eastell, J. S. San Martin, S. Ralston, 2019, Calcified Tissue International.

Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.

P. Chanson, A. Tabarin, F. Faucz, 2017, JCI insight.

A Phase 3 randomized, double-blind, placebo-controlled study investigating the efficacy and safety of Burosumab, an anti-FGF23 antibody, in adult X-Linked Hypophosphatemia (XLH)

R. Eastell, S. Ralston, M. Brandi, 2018 .

Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome.

E. Hindié, P. Chanson, A. Tabarin, 2022, Annales d'endocrinologie.

Development of spinal enthesopathies in adults with X-linked hypophosphatemia.

J. Herrou, K. Briot, C. Roux, 2023, The Journal of clinical endocrinology and metabolism.

Clinical, pathophysiologic, genetic and therapeutic progress in Primary Bilateral Macronodular Adrenal Hyperplasia.

J. Bertherat, A. Lacroix, I. Bourdeau, 2022, Endocrine reviews.

Genetic and epigenetic defects at the GNAS locus lead to distinct patterns of skeletal growth but similar early-onset obesity† Short title: Distinct patterns of fetal and post-natal growth in GNAS-related disorders

H. Jüppner, A. Rothenbuhler, A. Linglart, 2018 .

Combining metabolomics and machine learning models as a tool to distinguish non-classic 21-hydroxylase deficiency from polycystic ovary syndrome without adrenocorticotropic hormone testing.

Jacques Young, Y. Le Bouc, J. Salem, 2022, Human reproduction.

Treatment of acromegaly has substantial effects on body composition. A long-term follow-up study.

P. Chanson, Jacques Young, L. Maione, 2021, European journal of endocrinology.

Genotype-phenotype description of Vitamin-D Dependent Rickets 1A: CYP27B1 p.(Ala129Thr) variant induces a milder disease.

J. Bacchetta, A. Rothenbuhler, A. Linglart, 2022, The Journal of clinical endocrinology and metabolism.

X-linked hypophosphatemia and burosumab: practical clinical points from the French experience.

J. Salles, J. Bacchetta, K. Briot, 2021, Joint bone spine.

Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion

R. Dale, R. Mains, S. Stojilkovic, 2023, Frontiers in Endocrinology.

Pituitary surgery outcome in patients 75 years and older: a retrospective study

G. Assié, A. Bachelot, C. Courtillot, 2023, Acta Neurochirurgica.

Growth hormone excess and sternohyoid muscle mechanics in rats

P. Chanson, Y. Lecarpentier, V. Claes, 2009, European Respiratory Journal.

Acromegaly.

P. Chanson, S. Salenave, P. Kamenickỷ, 2014, Handbook of clinical neurology.

An Open-Label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism.

P. Kamenickỷ, S. Allas, M. G. Galvez Moreno, 2024, The Journal of clinical endocrinology and metabolism.

Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis. Five Years of Experience in a Clinical Laboratory.

C. Bouvattier, C. Verstuyft, P. Gaignard, 2021, Clinical chemistry.

Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors.

L. Maione, P. Kamenickỷ, Philippe Chanson, 2023, Archives of medical research.